Medifast, Inc. (MED) Earnings History
Annual and quarterly earnings data from 1996 to 2025
Loading earnings history...
MED EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
MED Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 71.3% | -3.7% | -4.8% |
| 2024 | 73.8% | 0.5% | 0.3% |
| 2023 | 72.4% | 11.8% | 9.3% |
| 2022 | 71.3% | 11.6% | 9.0% |
| 2021 | 73.9% | 14.2% | 10.7% |
Download Data
Export MED earnings history in CSV or JSON format
Free sign-in required to download data
Medifast, Inc. (MED) Earnings Overview
As of May 8, 2026, Medifast, Inc. (MED) reported trailing twelve-month net income of -$20M, reflecting -994.7% year-over-year growth. The company earned $-1.82 per diluted share over the past four quarters, with a net profit margin of -4.8%.
Looking at the long-term picture, MED's historical earnings data spans multiple years. The company achieved its highest annual net income of $164M in fiscal 2021.
Medifast, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including HIMS ($128M net income, 5.5% margin), NUS ($160M net income, 10.8% margin), USNA ($11M net income, 1.2% margin), MED has room to improve margins relative to the peer group. Compare MED vs HIMS →
MED Earnings vs Peers
Earnings metrics vs comparable public companies
MED Historical Earnings Data (1996–2025)
30 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$19M | -993.0% | -$14M | $-1.70 | -4.8% | -3.7% |
| 2024 | $2M | -97.9% | $3M | $0.19 | 0.3% | 0.5% |
| 2023 | $99M | -30.8% | $126M | $9.10 | 9.3% | 11.8% |
| 2022 | $144M | -12.5% | $185M | $12.73 | 9.0% | 11.6% |
| 2021 | $164M | +59.5% | $216M | $13.89 | 10.7% | 14.2% |
| 2020 | $103M | +32.0% | $134M | $8.68 | 11.0% | 14.4% |
| 2019 | $78M | +39.7% | $91M | $6.43 | 10.9% | 12.8% |
| 2018 | $56M | +101.3% | $69M | $4.62 | 11.1% | 13.8% |
| 2017 | $28M | +55.4% | $40M | $2.29 | 9.2% | 13.1% |
| 2016 | $18M | -11.1% | $27M | $1.49 | 6.5% | 9.8% |
See MED's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MED Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MED vs AMZN
Side-by-side business, growth, and profitability comparison vs Amazon.com, Inc..
Start ComparisonMED — Frequently Asked Questions
Quick answers to the most common questions about buying MED stock.
Is MED growing earnings?
MED EPS fell to $-1.82, with earnings declining -994.7%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-20M.
What are MED's profit margins?
Medifast, Inc. net margin is -4.8%, with operating margin at -3.7%. Below-average margins reflect competitive or cost pressures.
How consistent are MED's earnings?
MED earnings data spans 1996-2025. The declining earnings trend is -994.7% YoY. Historical data enables comparison across business cycles.